Lung Transplantation for Cystic Fibrosis

Clinics in Chest Medicine

Volumn 37, Issue 1, 2016, Pages 127-138

  Morrell, Matthew R ^a   Pilewski, Joseph M ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Advanced lung disease; Burkholderia cepacia; Cystic fibrosis; Lung transplantation; Nontuberculous mycobacteria; Respiratory failure

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTIFICIAL VENTILATION; ASPERGILLUS; ATYPICAL MYCOBACTERIUM; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BURKHOLDERIA CEPACIA; CADAVER DONOR; COMORBIDITY; CYSTIC FIBROSIS; DIABETES CONTROL; DIABETES MELLITUS; EXTRACORPOREAL OXYGENATION; FUNGUS CULTURE; GASTROINTESTINAL DISEASE; HUMAN; LIVER DISEASE; LONG TERM SURVIVAL; LUNG TRANSPLANTATION; MALNUTRITION; MORTALITY; OSTEOPOROSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARANASAL SINUS DISEASE; PATIENT EDUCATION; PATIENT REFERRAL; PATIENT SAFETY; PATIENT SELECTION; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUALITY OF LIFE; RESPIRATORY FAILURE; REVIEW; THORACOTOMY; THORAX SURGERY; COMPLICATION; LONG TERM CARE; PROCEDURES; RESPIRATORY INSUFFICIENCY; RISK FACTOR;

CYSTIC FIBROSIS; HUMANS; LIFE SUPPORT CARE; LUNG TRANSPLANTATION; REFERRAL AND CONSULTATION; RESPIRATORY INSUFFICIENCY; RISK FACTORS;

EID: 84959317612     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2015.11.008     Document Type: Review

References (70)

1. Yusen R.D., Edwards L.B., Kucheryavaya A.Y., et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report-2014; focus theme: retransplantation. J Heart Lung Transplant 2014, 33:1009-1024.
2. MacKenzie T., Gifford A.H., Sabadosa K.A., et al. Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry. Ann Intern Med 2014, 161:233-241.
3. Yacoub M.H., Banner N.R., Khaghani A., et al. Heart-lung transplantation for cystic fibrosis and subsequent domino heart transplantation. J Heart Transplant 1990, 9:459-466. [discussion: 466-7].
4. Kerem E., Reisman J., Corey M., et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992, 326:1187-1191.
5. Venuta F., Rendina E.A., De Giacomo T., et al. Timing and priorities for cystic fibrosis patients candidates to lung transplantation. Eur J Pediatr Surg 1998, 8:274-277.
6. Mayer-Hamblett N., Rosenfeld M., Emerson J., et al. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med 2002, 166:1550-1555.
7. Augarten A., Akons H., Aviram M., et al. Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. Pediatr Transplant 2001, 5:339-342.
8. Liou T.G., Adler F.R., Cahill B.C., et al. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA 2001, 286:2683-2689.
9. Weill D., Benden C., Corris P.A., et al. A consensus document for the selection of lung transplant candidates: 2014-an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2015, 34:1-15.
10. Mendeloff E.N., Huddleston C.B., Mallory G.B., et al. Pediatric and adult lung transplantation for cystic fibrosis. J Thorac Cardiovasc Surg 1998, 115:404-413. [discussion: 413-4].
11. Shennib H., Noirclerc M., Ernst P., et al. Double-lung transplantation for cystic fibrosis. The cystic fibrosis transplant study group. Ann Thorac Surg 1992, 54:27-31. [discussion: 31-2].
12. Venuta F., Diso D., Anile M., et al. Evolving techniques and perspectives in lung transplantation. Transplant Proc 2005, 37:2682-2683.
13. Meyers B.F., Sundaresan R.S., Guthrie T., et al. Bilateral sequential lung transplantation without sternal division eliminates posttransplantation sternal complications. J Thorac Cardiovasc Surg 1999, 117:358-364.
14. Cohen R.G., Barr M.L., Schenkel F.A., et al. Living-related donor lobectomy for bilateral lobar transplantation in patients with cystic fibrosis. Ann Thorac Surg 1994, 57:1423-1427. [discussion: 1428].
15. Date H., Sato M., Aoyama A., et al. Living-donor lobar lung transplantation provides similar survival to cadaveric lung transplantation even for very ill patients. Eur J Cardiothorac Surg 2015, 47:967-973.
16. Battafarano R.J., Anderson R.C., Meyers B.F., et al. Perioperative complications after living donor lobectomy. J Thorac Cardiovasc Surg 2000, 120:909-915.
17. Shigemura N., D'Cunha J., Bhama J.K., et al. Lobar lung transplantation: a relevant surgical option in the current era of lung allocation score. Ann Thorac Surg 2013, 96:451-456.
18. Stanzi A., Decaluwe H., Coosemans W., et al. Lobar lung transplantation from deceased donors: a valid option for small-sized patients with cystic fibrosis. Transplant Proc 2014, 46:3154-3159.
19. Flume P.A., Strange C., Ye X., et al. Pneumothorax in cystic fibrosis. Chest 2005, 128:720-728.
20. Meachery G., De Soyza A., Nicholson A., et al. Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax 2008, 63:725-731.
21. Hadjiliadis D., Steele M.P., Chaparro C., et al. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J Heart Lung Transplant 2007, 26:834-838.
22. Aris R.M., Gilligan P.H., Neuringer I.P., et al. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 1997, 155:1699-1704.
23. Murray S., Charbeneau J., Marshall B.C., et al. Impact of Burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med 2008, 178:363-371.
24. Alexander B.D., Petzold E.W., Reller L.B., et al. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant 2008, 8:1025-1030.
25. Boussaud V., Guillemain R., Grenet D., et al. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax 2008, 63:732-737.
26. Lobo L.J., Tulu Z., Aris R.M., et al. Pan-resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia infection in cystic fibrosis does not reduce survival after lung transplantation. Transplantation 2015, 99(10):2196-2202.
27. Dasenbrook E.C., Checkley W., Merlo C.A., et al. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 2010, 303:2386-2392.
28. Luong M.L., Chaparro C., Stephenson A., et al. Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis. Transplantation 2014, 97:351-357.
29. Symoens F., Knoop C., Schrooyen M., et al. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant 2006, 25:603-607.
30. Olivier K.N., Weber D.J., Wallace R.J., et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003, 167:828-834.
31. Olivier K.N., Weber D.J., Lee J.H., et al. Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med 2003, 167:835-840.
32. Chalermskulrat W., Sood N., Neuringer I.P., et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax 2006, 61:507-513.
33. Lobo L.J., Chang L.C., Esther C.R., et al. Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections. Clin Transplant 2013, 27:523-529.
34. Gilljam M., Schersten H., Silverborn M., et al. Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection. J Cyst Fibros 2010, 9:272-276.
35. Qvist T., Pressler T., Thomsen V.O., et al. Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population. Transplant Proc 2013, 45:342-345.
36. Nash K.L., Allison M.E., McKeon D., et al. A single centre experience of liver disease in adults with cystic fibrosis 1995-2006. J Cyst Fibros 2008, 7:252-257.
37. Rowland M., Gallagher C.G., O'Laoide R., et al. Outcome in cystic fibrosis liver disease. Am J Gastroenterol 2011, 106:104-109.
38. Nash E.F., Volling C., Gutierrez C.A., et al. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis. Clin Transplant 2012, 26:34-41.
39. Stephenson A.L., Sykes J., Berthiaume Y., et al. Clinical and demographic factors associated with post-lung transplantation survival in individuals with cystic fibrosis. J Heart Lung Transplant 2015, 34(9):1139-1145.
40. Lederer D.J., Wilt J.S., D'Ovidio F., et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am J Respir Crit Care Med 2009, 180:887-895.
41. Lowery E.M., Bemiss B., Cascino T., et al. Low vitamin D levels are associated with increased rejection and infections after lung transplantation. J Heart Lung Transplant 2012, 31:700-707.
42. Vital D., Hofer M., Benden C., et al. Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients. Respiration 2013, 86:25-31.
43. Vos R., Vanaudenaerde B.M., Geudens N., et al. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?. Eur Respir J 2008, 31:1037-1045.
44. Botha P., Archer L., Anderson R.L., et al. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 2008, 85:771-774.
45. Aris R.M., Renner J.B., Winders A.D., et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 1998, 128:186-193.
46. Aris R.M., Lester G.E., Renner J.B., et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med 2000, 162:941-946.
47. Aris R.M., Lester G.E., Caminiti M., et al. Efficacy of alendronate in adults with cystic fibrosis with low bone density. Am J Respir Crit Care Med 2004, 169:77-82.
48. Moran A., Dunitz J., Nathan B., et al. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009, 32:1626-1631.
49. Brennan A.L., Geddes D.M., Gyi K.M., et al. Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros 2004, 3:209-222.
50. Hackman K.L., Bailey M.J., Snell G.I., et al. Diabetes is a major risk factor for mortality after lung transplantation. Am J Transplant 2014, 14:438-445.
51. Bartz R.R., Love R.B., Leverson G.E., et al. Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosis. J Heart Lung Transplant 2003, 22:433-438.
52. Vermeijden J.W., Zijlstra J.G., Erasmus M.E., et al. Lung transplantation for ventilator-dependent respiratory failure. J Heart Lung Transplant 2009, 28:347-351.
53. Spahr J.E., Love R.B., Francois M., et al. Lung transplantation for cystic fibrosis: current concepts and one center's experience. J Cyst Fibros 2007, 6:334-350.
54. Moran F., Bradley J.M., Piper A.J. Non-invasive ventilation for cystic fibrosis. Cochrane Database Syst Rev 2013, (4). CD002769.
55. Bermudez C.A., Rocha R.V., Zaldonis D., et al. Extracorporeal membrane oxygenation as a bridge to lung transplant: midterm outcomes. Ann Thorac Surg 2011, 92:1226-1231. [discussion: 1231-2].
56. Toyoda Y., Bhama J.K., Shigemura N., et al. Efficacy of extracorporeal membrane oxygenation as a bridge to lung transplantation. J Thorac Cardiovasc Surg 2013, 145:1065-1070. [discussion: 1070-1].
57. Hayes D., Kukreja J., Tobias J.D., et al. Ambulatory venovenous extracorporeal respiratory support as a bridge for cystic fibrosis patients to emergent lung transplantation. J Cyst Fibros 2012, 11:40-45.
58. Liou T.G., Adler F.R., Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005, 171:1053-1059.
59. Liou T.G., Adler F.R., Cox D.R., et al. Lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2007, 357:2143-2152.
60. Sweet S.C., Aurora P., Benden C., et al. Lung transplantation and survival in children with cystic fibrosis: solid statistics-flawed interpretation. Pediatr Transplant 2008, 12:129-136.
61. Thabut G., Christie J.D., Mal H., et al. Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation. Am J Respir Crit Care Med 2013, 187:1335-1340.
62. Gee L., Abbott J., Conway S.P., et al. Validation of the SF-36 for the assessment of quality of life in adolescents and adults with cystic fibrosis. J Cyst Fibros 2002, 1:137-145.
63. Gee L., Abbott J., Conway S.P., et al. Quality of life in cystic fibrosis: the impact of gender, general health perceptions and disease severity. J Cyst Fibros 2003, 2:206-213.
64. Vermeulen K.M., van der Bij W., Erasmus M.E., et al. Improved quality of life after lung transplantation in individuals with cystic fibrosis. Pediatr Pulmonol 2004, 37:419-426.
65. Burker E.J., Carels R.A., Thompson L.F., et al. Quality of life in patients awaiting lung transplant: cystic fibrosis versus other end-stage lung diseases. Pediatr Pulmonol 2000, 30:453-460.
66. Gee L., Abbott J., Hart A., et al. Associations between clinical variables and quality of life in adults with cystic fibrosis. J Cyst Fibros 2005, 4:59-66.
67. Singer L.G., Chowdhury N.A., Faughnan M.E., et al. Effects of recipient age and diagnosis on health-related quality of life benefit of lung transplantation. Am J Respir Crit Care Med 2015, 192(8):965-973.
68. Busschbach J.J., Horikx P.E., van den Bosch J.M., et al. Measuring the quality of life before and after bilateral lung transplantation in patients with cystic fibrosis. Chest 1994, 105:911-917.
69. Quon B.S., Psoter K., Mayer-Hamblett N., et al. Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic status. Am J Respir Crit Care Med 2012, 186:1008-1013.
70. Merlo C.A., Clark S.C., Arnaoutakis G.J., et al. National healthcare delivery systems influence lung transplant outcomes for cystic fibrosis. Am J Transplant 2015, 15:1948-1957.